Real-time enrollment status for this lung cancer diagnosis clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:09 PM UTC
| NCT Number | NCT06122077 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer Diagnosis |
| Phase | Clinical Trial |
| Target Enrollment | 20,000 participants |
| Active Locations | 36 sites in the US |
| Sponsor | Freenome Holdings Inc. |
| Last Updated on CT.gov | August 5, 2025 (Aug 5, 2025) |
As of July 13, 2026: Clinical trial NCT06122077 is currently recruiting participants. This clinical trial study for lung cancer diagnosis is actively seeking new participants at 36 locations across the United States. The study is sponsored by Freenome Holdings Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06122077 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 36 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06122077 was last updated Aug 5, 2025 (August 5, 2025). HelloStudys verifies this status automatically.